Drusen prevalence and pigmentary changes in Caucasians aged 18-54 years

Eye (Basingstoke)

Volumn 26, Issue 10, 2012, Pages 1357-1362

  Silvestri, G ^a,b   Williams, M A ^b   McAuley, C ^a   Oakes, K ^a   Sillery, E ^a   Henderson, D C ^c   Ferguson, S ^d   Silvestri, V ^a   Muldrew, K A ^a  

^a QUEEN'S UNIVERSITY BELFAST   (United Kingdom)

^b ROYAL GROUP OF HOSPITALS TRUST   (United Kingdom)

^c Henderson's Optometry Practice   (United Kingdom)

^d Brogan's Optometry Practice   (United Kingdom)

Author keywords

Age related maculopathy; Drusen; Epidemiology; Macula; Pigmentary changes

Indexed keywords

VISUAL PIGMENT;

ADULT; AGE; ARTICLE; CAUCASIAN; DISEASE SEVERITY; DRUSEN; HUMAN; HUMAN EXPERIMENT; IMAGE QUALITY; OBSERVATIONAL STUDY; OPTOMETRY; PREVALENCE; RELIABILITY; RETINA IMAGE;

EID: 84867560362     PISSN: 0950222X     EISSN: 14765454     Source Type: Journal    
DOI: 10.1038/eye.2012.165     Document Type: Article

References (34)

1. Augood CA, Vingerling JR, de Jong PT, Chakravarthy U, Seland J, Soubrane G et al. Prevalence of age-related maculopathy in older Europeans: The European Eye Study (EUREYE). Arch Ophthalmol 2006; 124: 529-535.
2. Hogg RE, Stevenson MR, Chakravarthy U, Beirne RO, Anderson RS. Early features of AMD. Ophthalmology 2007; 114: 1028.
3. Klein R, Klein BE, Linton KL. Prevalence of age-related maculopathy. The Beaver Dam Eye Study. Ophthalmology 1992; 99: 933-943.
4. Vingerling JR, Dielemans I, Hofman A, Grobbee DE, Hijmering M, Kramer CF et al. The prevalence of age-related maculopathy in the Rotterdam Study. Ophthalmology 1995; 102: 205-210.
5. Mitchell P, Smith W, Attebo K, Wang JJ. Prevalence of age-related maculopathy in Australia. The Blue Mountains Eye Study. Ophthalmology 1995; 102: 1450-1460.
6. Cruickshanks KJ, Hamman RF, Klein R, Nondahl DM, Shetterly SM. The prevalence of age-related maculopathy by geographic region and ethnicity. The Colorado-Wisconsin Study of Age-Related Maculopathy. Arch Ophthalmol 1997; 115: 242-250.
7. VanNewkirk MR, Nanjan MB, Wang JJ, Mitchell P, Taylor HR, McCarty CA. The prevalence of age-related maculopathy: The visual impairment project. Ophthalmology 2000; 107: 1593-1600.
8. Friedman DS, O0Colmain BJ, Munoz B, Tomany SC, McCarty C, de Jong PT et al. Prevalence of age-related macular degeneration in the United States. Arch Ophthalmol 2004; 122: 564-572.
9. Munoz B, Klein R, Rodriguez J, Snyder R, West SK. Prevalence of age-related macular degeneration in a population-based sample of Hispanic people in Arizona: Proyecto VER. Arch Ophthalmol 2005; 123: 1575-1580.
10. Gupta SK, Murthy GV, Morrison N, Price GM, Dherani M, John N et al. Prevalence of early and late age-related macular degeneration in a rural population in northern India: The INDEYE feasibility study. Invest Ophthalmol Vis Sci 2007; 48: 1007-1011.
11. Tikellis G, Robman LD, Dimitrov P, Nicolas C, McCarty CA, Guymer RH. Characteristics of progression of early agerelated macular degeneration: The cardiovascular health and age-related maculopathy study. Eye (Lond) 2007; 21: 169-176.
12. Varma R, Fraser-Bell S, Tan S, Klein R, Azen SP. Prevalence of age-related macular degeneration in Latinos: The Los Angeles Latino eye study. Ophthalmology 2004; 111: 1288-1297.
13. Dickinson AJ, Sparrow JM, Duke AM, Thompson JR, Gibson JM, Rosenthal AR. Prevalence of age-related maculopathy at two points in time in an elderly British population. Eye (Lond) 1997; 11, (Pt 3) 301-314.
14. Friedman DS, Katz J, Bressler NM, Rahmani B, Tielsch JM. Racial differences in the prevalence of age-related macular degeneration: The Baltimore Eye Survey. Ophthalmology 1999; 106: 1049-1055.
15. Bressler NM, Munoz B, Maguire MG, Vitale SE, Schein OD, Taylor HR et al. Five-year incidence and disappearance of drusen and retinal pigment epithelial abnormalities. Waterman study. Arch Ophthalmol 1995; 113: 301-308.
16. Klein R, Klein BE, Knudtson MD, Meuer SM, Swift M, Gangnon RE. Fifteen-year cumulative incidence of agerelated macular degeneration: The Beaver Dam Eye Study. Ophthalmology 2007; 114: 253-262.
17. Buch H, Nielsen NV, Vinding T, Jensen GB, Prause JU, la Cour M. 14-year incidence, progression, and visual morbidity of age-related maculopathy: The Copenhagen City Eye Study. Ophthalmology 2005; 112: 787-798.
18. Jonasson F, Arnarsson A, Peto T, Sasaki H, Sasaki K, Bird AC. 5-year incidence of age-related maculopathy in the Reykjavik Eye Study. Ophthalmology 2005; 112: 132-138.
19. Sparrow JM, Dickinson AJ, Duke AM, Thompson JR, Gibson JM, Rosenthal AR. Seven year follow-up of age-related maculopathy in an elderly British population. Eye (Lond) 1997; 11, (Pt 3) 315-324.
20. van Leeuwen R, Klaver CC, Vingerling JR, Hofman A, de Jong PT. The risk and natural course of age-related maculopathy: Follow-up at 6 1/2 years in the Rotterdam study. Arch Ophthalmol 2003; 121: 519-526.
21. Wang JJ, Rochtchina E, Lee AJ, Chia EM, Smith W, Cumming RG et al. Ten-year incidence and progression of age-related maculopathy: The blue Mountains Eye Study. Ophthalmology 2007; 114: 92-98.
22. Mukesh BN, Dimitrov PN, Leikin S, Wang JJ, Mitchell P, McCarty CA et al. Five-year incidence of age-related maculopathy: The Visual Impairment Project. Ophthalmology 2004; 111: 1176-1182.
23. Schachat AP, Hyman L, Leske MC, Connell AM, Wu SY. Features of age-related macular degeneration in a black population. The Barbados Eye Study Group. Arch Ophthalmol 1995; 113: 728-735.
24. Bressler NM, Bressler SB, West SK, Fine SL, Taylor HR. The grading and prevalence of macular degeneration in Chesapeake Bay watermen. Arch Ophthalmol 1989; 107: 847-852.
25. Klein R, Davis MD, Magli YL, Segal P, Klein BE, Hubbard L. The Wisconsin age-related maculopathy grading system. Ophthalmology 1991; 98: 1128-1134.
26. Klein R, Klein BE, Jensen SC, Meuer SM. The five-year incidence and progression of age-related maculopathy: The Beaver Dam Eye Study. Ophthalmology 1997; 104: 7-21.
27. Munch IC, Sander B, Kessel L, Hougaard JL, Taarnhoj NC, Sorensen TI et al. Heredity of small hard drusen in twins aged 20-46 years. Invest Ophthalmol Vis Sci 2007; 48: 833-838.
28. Sarks SH, Arnold JJ, Killingsworth MC, Sarks JP. Early drusen formation in the normal and aging eye and their relation to age related maculopathy: A clinicopathological study. Br J Ophthalmol 1999; 83: 358-368.
29. Wang Q, Chappell RJ, Klein R, Eisner A, Klein BE, Jensen SC et al. Pattern of age-related maculopathy in the macular area. The Beaver Dam Eye Study. Invest Ophthalmol Vis Sci 1996; 37: 2234-2242.
30. Traboulsi EI. The challenges and surprises of studying the genetics of age-related macular degeneration. Am J Ophthalmol 2005; 139: 908-911.
31. Tao Y, Jonas JB. Refractive error and smoking habits in exudative age-related macular degeneration in a hospitalbased setting. Eye 2010; 24: 648-652.
32. AREDS Coordinating Center. T.E.C. Risk factors associated with age-related macular degeneration. A case-control study in the age-related eye disease study: Age-Related Eye Disease Study Report Number 3. Age-Related Eye Disease Study Research Group. Ophthalmology 2000; 107: 2224-2232.
33. Ikram MK, van Leeuwen R, Vingerling JR, Hofman A, de Jong PT. Relationship between refraction and prevalent as well as incident age-related maculopathy: The Rotterdam Study. Invest Ophthalmol Vis Sci 2003; 44: 3778-3782.
34. Wang Q, Klein KB, Moss R. SE. Refractive Status in Beaver Dam Eye Study. IOVS 1994; 35: 4344-4347.